A transcriptional regulatory network of HNF4α and HNF1α involved in human diseases and drug metabolism

Drug Metab Rev. 2022 Nov;54(4):361-385. doi: 10.1080/03602532.2022.2103146. Epub 2022 Jul 26.

Abstract

HNF4α and HNF1α are core transcription factors involved in the development and progression of a variety of human diseases and drug metabolism. They play critical roles in maintaining the normal growth and function of multiple organs, mainly the liver, and in the metabolism of endogenous and exogenous substances. The twelve isoforms of HNF4α may exhibit different physiological functions, and HNF4α and HNF1α show varying or even opposing effects in different types of diseases, particularly cancer. Additionally, the regulation of CYP450, phase II drug-metabolizing enzymes, and drug transporters is affected by several factors. This article aims to review the role of HNF4α and HNF1α in human diseases and drug metabolism, including their structures and physiological functions, affected diseases, regulated drug metabolism genes, influencing factors, and related mechanisms. We also propose a transcriptional regulatory network of HNF4α and HNF1α that regulates the expression of target genes related to disease and drug metabolism.

Keywords: CYP450; HNF1α; HNF4α; drug metabolism; human diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytochrome P-450 Enzyme System / genetics
  • Cytochrome P-450 Enzyme System / metabolism
  • Gene Regulatory Networks
  • Hepatocyte Nuclear Factor 4* / genetics
  • Hepatocyte Nuclear Factor 4* / metabolism
  • Humans
  • Inactivation, Metabolic* / genetics
  • Liver* / metabolism
  • Pharmaceutical Preparations / metabolism

Substances

  • Cytochrome P-450 Enzyme System
  • Hepatocyte Nuclear Factor 4
  • HNF4A protein, human
  • HNF1A protein, human
  • Pharmaceutical Preparations